Histopathologic and apoptotic effect of nanosilver in liver of broiler chickens by Loghman, A et al.
African Journal of Biotechnology Vol. 11(22), pp. 6207-6211, 15 March, 2012     
Available online at http://www.academicjournals.org/AJB 
DOI: 10.5897/AJB11.1768 




Full Length Research Paper 
 
Histopathologic and apoptotic effect of nanosilver in 
liver of broiler chickens 
 
Akradi Loghman1*, Sohrabi Haghdoost Iraj1, Djeddi Ali Naghi2 and Mortazavi Pejman1 
 
1
Department of Pathology, Faculty of Specialized Veterinary Sciences, Science and Research Branch, Islamic Azad 
University, Tehran, Iran. 
2
Department of Clinical Science, Faculty of Veterinary Medicine, Sanandaj Branch, Islamic Azad University, Sanandaj, 
Iran. 
 
Accepted 19 September, 2011 
 
Silver nanoparticles can destroy bacteria, viruses and fungi; therefore, it is recommended as a 
disinfectant and can be used as a drug in the treatment of some non-curable viral disease in livestock. 
The aim of the present investigation was to study the effects of nanosilver induced toxicity on the liver 
of broiler chickens. This study was carried out on 240 one-day-old male broiler chickens (Ross 308) in a 
completely randomized design (CRD) in four treatments at 0 (control), 4, 8 and 12 ppm levels of silver 
nanoparticles that was added daily to the drinking water with four repetitions within 16 separate cages 
and 15 birds in each pen. At the end of the experiment (day 42), 32 chicks were randomly selected and 
slaughtered thereafter, H&E, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
staining and light microscope was used to examine livers. Liver histopathology and H&E staining 
showed dose depended changes such as fatty degeneration, sinusoidal congestion, central vein 
dilatation, necrosis in hepatocytes and fibrosis. TUNEL staining showed significant (p<0.01) increase of 
apoptotic cells in groups 3 (8 ppm) and 4 (12 ppm). Data were statistically analyzed using ANOVA. 
Lesions and apoptotic cells in groups 3 (8 ppm) and 4 (12 ppm) were more severe than in group 2 (4 
ppm). It can be concluded that higher concentrations of nanosilver (8 and 12 ppm) can induce sever 
lesions in chickens liver. 
 





Nanoparticles mean particles of size in the range of 1 to 
100 nm. When a macroscopic object is made into nano-
particles, its physical and chemical properties change 
greatly when compared with the normal materials. 
Nanomaterials are widely used in many fields such as the 
chemical industry and biomedicine. Nanosilver is one of 
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strong disinfectant properties (Chen et al., 2007). It has 
much stronger germicidal capability which can kill up to 
650 different types of bacteria (Kim et al., 2007). The 
inhibitory effect of ionic silver is due to several biological 
events such as attachment to cell membranes, its 
adsorption to the negatively charged bacterial cell wall, 
changes of membrane permeability, generating reactive 
oxygen species (ROS) and de-activating cellular 
enzymes. These features may be having negative effects 
on health and the environment, and lead to high toxicity 
of nanosilver (El-ansary and Al-Daihan, 2008).  
Nanosilver solution is composed of colloidal suspen-
sions of silver ions and is more stable than other 
solutions. Silver nanoparticles can destroy many kinds of 
bacteria, viruses and fungi and it is recommended that it 
can be used in the treatment of certain viral diseases in 
animals like Influenza and Newcastle (Ahari et al., 2008). 
However, this substance, like many other drugs has  side  




Table 1. Statistical analysis of apoptotic effect of nanosilver. There is no significant difference 
between treatment1 (4 ppm) and control group (P>0.05) but differences between treatments 2 
and 3 with the control group is significant (P<0.01). 
 
Treatment Control Tr.1 (4 ppm) Tr.2 (8 ppm) Tr.3 (12 ppm) 
Apoptosis ± SD 1 ± 0.7
b
 1.8 ± 0.8
b
 8.6 ± 2.7
a






effects and pathologic effect on living tissues. Drugs that 
enter the body are metabolized in liver and often excreted 
through the kidneys, and then they are affected more 
than other tissues. 
As a result of nanosilver special characteristic of killing 
bacteria, antimicrobial materials containing nanosilver are 
becoming increasingly important because of their wide 
range of applications. Despite the widespread use of 
nanosilver products, relatively few studies have been 
undertaken to determine the biological effects of nano-
silver exposure. The purpose of this present study was to 
evaluate the toxicity of nanosilver and to observe 
pathological and morphological changes in the liver of 
broiler chickens by an optical microscope. 
 
 
MATERIALS AND METHODS 
 
This research was carried out on 240 one-day-old male broiler 
chicks (Ross 308) in a completely randomized design (CRD) in four 
treatments at 0 (control), 4, 8 and 12-ppm levels of silver 
nanoparticles that was added daily to drinking water with four 
repetitions within 16 separate cages and 15 birds in each pen. 
Factors such as temperature, light, water, ventilation, nutrition and 
vaccination were similar for all treatments. Nanosilver used in this 
study was nanocid (Nanocid L2000) containing 4000 ppm
 
per liter 
silver nano-particles with average size of 18 nm. Diet of chickens 
was prepared as starter (0 to 21 days) and grower (42 to 21 days) 
based on corn and soybean meal and was available to all 
treatments. Vaccination programs for all treatments include 
bronchitis, influenza, Newcastle and Gumboro. 
At the end of the growing period (day 42), two chickens from 
each cage with the average weight was slaughtered and tissue 
samples were immediately isolated from liver and were fixed in 10% 
buffered formalin. Samples were taken to the laboratory, after 
tissue processing and cutting, they were placed on glass slides, 
and stained with H&E for review of tissue lesions. Apoptotic effects 
of nanosilver was investigated by using immunohistochemistry 
method of indirect streptavidin biotin peroxidase TUNEL assay 
(Dead End
TM
 Colorimetric TUNEL System G7130,promega), and 
nuclear DNA fragments of apoptotic cells were seen as dark brown 





Histopathologic effect (hematoxylin-eosin staining) 
 
The control group showed healthy liver tissue with no 
specific lesion (Figure 1A). In the first treatment (4 ppm), 
infrequent accumulations in the hepatocytes (cell 
swelling) and hyperemia was seen (Figure 1B). Second 
and third treatments (8 and 12 ppm) showed dilated 
central vein, hyperemia with severe fatty change. In the 
third treatment (12 ppm), increased connective tissue 
(fibroplasia) and focal necrosis of hepatocytes was 
observed (Figure 1D). 
 
 
Immunohistochemistry method (TUNEL staining) 
 
Nucleus of apoptotic cells was dark brown in color and 
detectable from other cells. In the control group, the 
number of these cells was very low (Figure 2E), but in 
treatment groups, they increased and there was an 
increase in nanosilver concentration (Figure 2F, G and 
H). 
For counting of the number of apoptotic cells in 
microscopic sections, apoptotic cells were randomly 
counted in 10 microscopic fields with magnification of 40. 
Results were statistically analyzed using ANOVA and 
Tukey methods. There was no significant difference 
between first treatment (4 ppm) and control group 
(P>0.05) but differences between second and third 
treatments with the control group is highly significant (P 





There is no consensus on the cytotoxicity of nanosilver, 
however, most publications do show reduced cell viability 
following exposure. Additional toxic effects seen in the in 
vitro studies are glutathione depletion, mitochondrial 
deviations or destruction and damage to cell membranes. 
Nanosilver enters the body through the skin, respiratory 
system and gastrointestinal tract. The most important 
way to contact it, especially in the gastrointestinal tract is 
in colloidal form (Chang et al., 2006). Absorbed nano-
silvers bind to plasma proteins and can enter the cells. 
They are distributed in organs such as liver, kidney, 
heart, lymph nodes, brain, lung, stomach and testicles 
(Wijnhoven et al., 2009). Absorbed nanosilvers from 
gastrointestinal tract enter liver through the portal vein 
and might have impact on the liver since the liver serves 
as the first checkpoint for everything absorbed before 
becoming systemic. Liver is able to actively remove 
compounds from the blood and transform them to 
chemical forms that can easily be excreted. It is a logical 
assumption that ingested silver nano-particles might have 
impact on the liver. Significant amounts of silver in the 
liver were observed after inhalation  (Ji  et  al.,  2007).  Its  






Figure 1. Histopathologic effect of NS on liver. A: Control group with no lesion; B: first treatment (4 ppm) with 
cell swelling (arrow); C: second treatment (8 ppm) with dilated central vein (arrow); D: third treatments (12 




renal excretion via the urine has been detected (Trop et 
al., 2006). Recently, it has been reported that nano-
particles and nano-materials generate free radicals and 
oxidative stress. The results of researches showed that 
silver nano-particles could damage different organs and 
tissue such as liver cells.  
Microscopic studies demonstrated that absorbed nano-
silver cause mild to severe dose dependent lesions in 
hepatocytes such as necrosis of liver cells, focal 
accumulation of inflammatory cells and increase of 
connective tissue (fibroplasias). Due to toxicity of silver, 
further study was conducted with reference to its 
oxidative stress (Xia et al., 2006). Most studies have 
reported decrease of cellular activities due to glutathione 
depletion, damage to the mitochondria and cell mem-
brane such as increased levels of liver enzymes following 
the use of silver-containing wound bond (Trop et al., 
2006), toxic effect on rat liver cells due to effect on 
mitochondrial activity and membrane permeability and 
toxicity on neuroendocrin cells (Hussain et al., 2006), 
human respiratory alveolar epithelium (Park et al., 2007), 
rat alveolar macrophages (Soto et al., 2007), several 
focal haemorrhages, fibroplasias and reduction of 
lymphocyte in the lymphoid follicles of Bursa Fabricius 
(Djeddi et al., 2008). 
Hussain et al. (2005) studied the toxicity of silver nano-
particles on rat liver cell line (BRL 3A). They found that 
the mitochondrial displayed abnormal size, cellular 
shrinkage and irregular shape. In the study with BRL 3A 
liver cell line, depletion of GSH level, reduced mito-
chondrial membrane potential and increased ROS was 
found in association with mitochondrial perturbation, 
suggesting that oxidative stress might mediate the 
cytotoxicity of silver nano-particles. 
Braydich-Stolle et al. (2005) reported the toxicity of 
silver nano-particles on C18-4 cell, a cell line with 
spermatogonial stem cell characteristics. From the study, 
it was concluded that the cytotoxicity of silver nano-
particles to the mitochondrial activity increased with the 
increase in the concentration of silver nano-particles. The 
results show that silver nano-particles were the most 
toxic with drastic reduction of mitochondrial function, 
increased membrane leakage, necrosis and induction of 
apoptosis. Ji et al. (2007) reported a clear dose depen-
dent increase of cytoplasmic vacuolization in liver cells 
and several cases of hepatic focal necrosis in the high 
dose groups. 
Kim et al. (2008) showed that repeated oral doses of 
nanosilver for 28 days did induce liver toxicity, as shown 
by increases in ALP and histopathological observations 
of dilatation of the central vein, bile-duct hyperplasia and 
increased foci. Also, nanosilver cause hepatocyte 
apoptosis in high concentration (more than 8 ppm). This 
apoptotic effect of nanosilver has  been  reported  in  both  






Figure 2. TUNEL staining of liver sections (400x). E: Control group; F: first treatment (4 ppm); G: second treatment 




cancer and non-cancer cells in vitro (Gopinath et al., 
2008), in inflammatory cell (Sung et al., 2008) and in 
fibroblasts due to release of cytochrome c into the cytosol 
and translocation of Bax to mitochondria. Nanosilver-
induced apoptosis was associated with the generation of 
reactive oxygen species (ROS) and JNK activation, 
showing that nanosilver acts through ROS and JNK to 
induce apoptosis via the mitochondrial pathway (Hsin et 
al., 2008). Over accumulation of ROS can initiate an 
inflammatory response, perturbation and destruction of 
the mitochondria takes place. Then, apoptogenic factors 
like cytochrome C are released and programmed cell 
death is a final result.  
In mice, application of a 1% nano-silver cream inhibited 
allergic contact dermatitis (Bhol and Schechter, 2005). It 
was found that the expression of two cytokines (TNFa 
and IL-12) was suppressed and apoptosis of inflam-
matory cells but not keratinocytes was induced.  
Silver nanoparticles decreased the function of mito-
chondria and apoptosis or apoptosis-like change of cell 
morphology also occurred in cell lines following exposure 
(Braydich et al., 2005; Hussain et al.; 2005, 2006). 
Dysfunction of mitochondria is an early and key step 
towards apoptosis. Thus, mitochondria seem to be 
sensitive targets of cytotoxicity of silver nanoparticles. In 
the study with BRL 3A liver cell line, depletion of GSH 
level and increased ROS was found in association with 
mitochondrial perturbation, suggesting that oxidative 
stress might mediate the cytotoxicity of silver nano-





Nanosilver causes argyria and argyriosis in humans and 
has pathologic effects on liver, kidney, eye, skin, 
respiratory and digestive system (Drake and Hazelwood, 
2005; Nagnder et al., 2008). This study shows its (more 
than 4 ppm) harmful effect on the liver cells, especially in 
broilers, and recommended the use of nanosilver as anti 
microbial agent in poultry industry with caution and that 
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